US Stock MarketDetailed Quotes

CSBR Champions Oncology

Watchlist
  • 4.900
  • -0.150-2.97%
Close Jul 23 16:00 ET
66.61MMarket Cap-9074P/E (TTM)

Champions Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
(Q1)Jul 31, 2022
Total revenue
-6.90%50.16M
7.12%14M
-5.90%12.02M
-18.96%11.57M
-8.61%12.56M
9.69%53.87M
1.51%13.07M
-3.18%12.77M
21.17%14.28M
22.15%13.75M
Operating revenue
-6.90%50.16M
5.32%16.22M
-7.76%11.18M
-19.73%10.88M
-7.19%11.88M
14.91%53.87M
24.54%15.4M
-4.13%12.13M
21.60%13.55M
19.30%12.8M
Cost of revenue
-0.44%29.4M
-1.20%7.25M
1.95%7.85M
-11.08%6.62M
8.96%7.68M
24.97%29.53M
17.96%7.34M
20.18%7.7M
32.70%7.44M
30.69%7.05M
Gross profit
-14.73%20.75M
17.77%6.75M
-17.82%4.17M
-27.54%4.96M
-27.13%4.88M
-4.47%24.34M
-13.87%5.73M
-25.24%5.07M
10.70%6.84M
14.27%6.69M
Operating expense
-3.86%27.68M
-11.53%6.59M
-10.42%6.75M
1.16%6.91M
6.48%7.43M
15.75%28.79M
6.89%7.45M
26.44%7.53M
15.51%6.83M
15.67%6.98M
Selling and administrative expenses
5.16%18.13M
-1.24%4.54M
5.33%4.56M
3.97%4.4M
13.35%4.64M
11.27%17.24M
5.00%4.6M
14.67%4.33M
16.93%4.23M
9.71%4.09M
-Selling and marketing expense
0.89%7.06M
-3.95%1.78M
2.04%1.8M
5.59%1.8M
0.24%1.7M
9.77%7M
14.49%1.85M
13.69%1.76M
3.66%1.7M
7.50%1.69M
-General and administrative expense
8.08%11.07M
0.58%2.76M
7.59%2.76M
2.89%2.6M
22.60%2.94M
12.32%10.24M
-0.54%2.75M
15.36%2.57M
27.95%2.53M
11.33%2.4M
Research and development costs
-17.33%9.54M
-28.12%2.05M
-31.73%2.19M
-3.42%2.52M
-3.26%2.79M
23.16%11.55M
10.07%2.85M
46.81%3.2M
13.27%2.6M
25.30%2.89M
Operating profit
-55.56%-6.92M
109.57%164K
-4.84%-2.58M
-28,028.57%-1.96M
-798.59%-2.55M
-832.95%-4.45M
-451.13%-1.71M
-396.14%-2.46M
-97.34%7K
-62.29%-284K
Net non-operating interest income expense
Other net income (expense)
52.69%-387K
57.19%-354K
61.11%58K
-1,066.67%-105K
177.78%14K
-3,308.33%-818K
-2,262.86%-827K
212.50%36K
-134.62%-9K
-205.88%-18K
Special income (charges)
46.10%-435K
----
----
----
----
---807K
----
----
----
----
-Write off
--0
----
----
----
----
--807K
----
----
----
----
-Gain on sale of property,plant,equipment
---435K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
536.36%48K
505.00%81K
61.11%58K
-1,066.67%-105K
177.78%14K
54.17%-11K
42.86%-20K
212.50%36K
-134.62%-9K
-205.88%-18K
Income before tax
-38.75%-7.31M
92.52%-190K
-4.00%-2.52M
-102,900.00%-2.06M
-740.40%-2.54M
-1,003.43%-5.27M
-634.39%-2.54M
-403.51%-2.42M
-100.69%-2K
-91.14%-302K
Income tax
-147.06%-32K
-505.00%-81K
-35.29%11K
-21.43%11K
64.71%28K
94.29%68K
1,100.00%20K
54.55%17K
16.67%14K
21.43%17K
Net income
-36.38%-7.28M
95.74%-109K
-3.73%-2.53M
-12,843.75%-2.07M
-704.39%-2.57M
-1,073.54%-5.34M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16K
-85.47%-319K
Net income continuous Operations
-36.38%-7.28M
95.74%-109K
-3.73%-2.53M
-12,843.75%-2.07M
-704.39%-2.57M
-1,073.54%-5.34M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16K
-85.47%-319K
Minority interest income
Net income attributable to the parent company
-36.38%-7.28M
95.74%-109K
-3.73%-2.53M
-12,843.75%-2.07M
-704.39%-2.57M
-1,073.54%-5.34M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16K
-85.47%-319K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.38%-7.28M
95.74%-109K
-3.73%-2.53M
-12,843.75%-2.07M
-704.39%-2.57M
-1,073.54%-5.34M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16K
-85.47%-319K
Basic earnings per share
-38.46%-0.54
94.74%-0.01
-5.56%-0.19
-12,579.63%-0.15
-850.00%-0.19
-1,075.00%-0.39
-533.33%-0.19
-400.00%-0.18
-105.92%-0.0012
-100.00%-0.02
Diluted earnings per share
-38.46%-0.54
94.74%-0.01
-5.56%-0.19
-12,579.63%-0.15
-850.00%-0.19
-1,075.00%-0.39
-533.33%-0.19
-460.00%-0.18
-105.92%-0.0012
-100.00%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023(Q2)Oct 31, 2022(Q1)Jul 31, 2022
Total revenue -6.90%50.16M7.12%14M-5.90%12.02M-18.96%11.57M-8.61%12.56M9.69%53.87M1.51%13.07M-3.18%12.77M21.17%14.28M22.15%13.75M
Operating revenue -6.90%50.16M5.32%16.22M-7.76%11.18M-19.73%10.88M-7.19%11.88M14.91%53.87M24.54%15.4M-4.13%12.13M21.60%13.55M19.30%12.8M
Cost of revenue -0.44%29.4M-1.20%7.25M1.95%7.85M-11.08%6.62M8.96%7.68M24.97%29.53M17.96%7.34M20.18%7.7M32.70%7.44M30.69%7.05M
Gross profit -14.73%20.75M17.77%6.75M-17.82%4.17M-27.54%4.96M-27.13%4.88M-4.47%24.34M-13.87%5.73M-25.24%5.07M10.70%6.84M14.27%6.69M
Operating expense -3.86%27.68M-11.53%6.59M-10.42%6.75M1.16%6.91M6.48%7.43M15.75%28.79M6.89%7.45M26.44%7.53M15.51%6.83M15.67%6.98M
Selling and administrative expenses 5.16%18.13M-1.24%4.54M5.33%4.56M3.97%4.4M13.35%4.64M11.27%17.24M5.00%4.6M14.67%4.33M16.93%4.23M9.71%4.09M
-Selling and marketing expense 0.89%7.06M-3.95%1.78M2.04%1.8M5.59%1.8M0.24%1.7M9.77%7M14.49%1.85M13.69%1.76M3.66%1.7M7.50%1.69M
-General and administrative expense 8.08%11.07M0.58%2.76M7.59%2.76M2.89%2.6M22.60%2.94M12.32%10.24M-0.54%2.75M15.36%2.57M27.95%2.53M11.33%2.4M
Research and development costs -17.33%9.54M-28.12%2.05M-31.73%2.19M-3.42%2.52M-3.26%2.79M23.16%11.55M10.07%2.85M46.81%3.2M13.27%2.6M25.30%2.89M
Operating profit -55.56%-6.92M109.57%164K-4.84%-2.58M-28,028.57%-1.96M-798.59%-2.55M-832.95%-4.45M-451.13%-1.71M-396.14%-2.46M-97.34%7K-62.29%-284K
Net non-operating interest income expense
Other net income (expense) 52.69%-387K57.19%-354K61.11%58K-1,066.67%-105K177.78%14K-3,308.33%-818K-2,262.86%-827K212.50%36K-134.62%-9K-205.88%-18K
Special income (charges) 46.10%-435K-------------------807K----------------
-Write off --0------------------807K----------------
-Gain on sale of property,plant,equipment ---435K------------------0----------------
Other non- operating income (expenses) 536.36%48K505.00%81K61.11%58K-1,066.67%-105K177.78%14K54.17%-11K42.86%-20K212.50%36K-134.62%-9K-205.88%-18K
Income before tax -38.75%-7.31M92.52%-190K-4.00%-2.52M-102,900.00%-2.06M-740.40%-2.54M-1,003.43%-5.27M-634.39%-2.54M-403.51%-2.42M-100.69%-2K-91.14%-302K
Income tax -147.06%-32K-505.00%-81K-35.29%11K-21.43%11K64.71%28K94.29%68K1,100.00%20K54.55%17K16.67%14K21.43%17K
Net income -36.38%-7.28M95.74%-109K-3.73%-2.53M-12,843.75%-2.07M-704.39%-2.57M-1,073.54%-5.34M-644.48%-2.56M-409.91%-2.44M-105.78%-16K-85.47%-319K
Net income continuous Operations -36.38%-7.28M95.74%-109K-3.73%-2.53M-12,843.75%-2.07M-704.39%-2.57M-1,073.54%-5.34M-644.48%-2.56M-409.91%-2.44M-105.78%-16K-85.47%-319K
Minority interest income
Net income attributable to the parent company -36.38%-7.28M95.74%-109K-3.73%-2.53M-12,843.75%-2.07M-704.39%-2.57M-1,073.54%-5.34M-644.48%-2.56M-409.91%-2.44M-105.78%-16K-85.47%-319K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.38%-7.28M95.74%-109K-3.73%-2.53M-12,843.75%-2.07M-704.39%-2.57M-1,073.54%-5.34M-644.48%-2.56M-409.91%-2.44M-105.78%-16K-85.47%-319K
Basic earnings per share -38.46%-0.5494.74%-0.01-5.56%-0.19-12,579.63%-0.15-850.00%-0.19-1,075.00%-0.39-533.33%-0.19-400.00%-0.18-105.92%-0.0012-100.00%-0.02
Diluted earnings per share -38.46%-0.5494.74%-0.01-5.56%-0.19-12,579.63%-0.15-850.00%-0.19-1,075.00%-0.39-533.33%-0.19-460.00%-0.18-105.92%-0.0012-100.00%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg